In one of the biggest breakthroughs in schizophrenia research in recent times, Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies.
One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. The current treatments for schizophrenia are designed to suppress symptoms rather than target underlying causes of the disorder. These drugs only partially relieve symptoms and can produce unwanted side effects.
To recognise the significance of this discovery Professor Shannon Weickert says you first need to understand most scientists have had a long held belief that immune cells were independent from the brain pathology in psychotic illnesses.
“In our study, we challenged this assumption that immune cells were independent of the brain in psychiatric illness and made an exciting discovery. We identified immune cells as a new player in the brain pathology of schizophrenia,” said Professor Shannon Weickert.
Current schizophrenia research has focused on the status of three brain cells: the neurons; the glial cells, which support the neurons; and the endothelial cells, which coat the blood vessels. Employing new molecular techniques allowed Professor Shannon Weickert and her team to identify the presence of a fourth cell, the macrophage, a type of immune cell in the brain tissue of people with schizophrenia who show high levels of inflammation.
Professor Shannon Weickert said immune cells have previously been ignored as they had long been viewed simply as travelers just thought to be passing by, undertaking surveillance work. They have never been a suspect until now.
“To find immune cells along the blood brain barrier in increased amounts in people with schizophrenia is an exciting discovery. It suggests immune cells themselves may be producing these inflammatory signals in the brains of people living with schizophrenia,” said Professor Shannon Weickert.
“We have observed in people with schizophrenia, the glial cells, one of the local residents, become inflamed and produce distress signals which change the status of the endothelial cells.
“We think this may cause the endothelial cells to extend sticky tentacles, so when the immune cells travel by some are captured. These cells may transmigrate across the blood brain barrier entering the brain in greater amounts in some people with schizophrenia compared to people without the disorder.”
This discovery shows that specific immune cells are in the brains of some people with schizophrenia in close enough proximity to the neurons to do damage.
Professor Peter Schofield, CEO of NeuRA said this innovative new research has the ability to alter the way in which we may be able to diagnose and treat schizophrenia.
“This breakthrough demonstrates the value of the NSW Government’s support for Professor Shannon Weickert as NSW Chair of Schizophrenia Research, which has delivered new insights that the community seeks,” said Professor Schofield.
Professor Shannon Weickert is encouraging a cross-collaborative approach between neuroscientists and immunologists globally, to work together to develop treatments targeting this abnormal immune pathology of schizophrenia.
“This opens whole new avenues for therapy, because it suggests that the pathology of schizophrenia could be within the immune cells and the immune cells could be contributing to the symptoms of schizophrenia,” said Professor Shannon Weickert.
Professor Shannon Weickert is uniquely motivated in her work, with her twin-brother being diagnosed with schizophrenia when he was 17 years old.
Learn more: Schizophrenia breakthrough
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
6 Myths (And Facts) About Schizophrenia You Really Need to Know
on May 25, 2019 at 7:12 am
Schizophrenia is a severe, chronic and often debilitating mental illness, which can produce a number of difficulties in a number of life domains. Adding to this complexity is the stigma and ... […]
Broccoli Sprout Compound May Help Restore Brain Chemistry Imbalance in Schizophrenia
on May 24, 2019 at 4:38 am
In a series of recently published studies in humans and animals, Johns Hopkins Medicine researchers say they have identified certain glutamate-related chemical imbalances in the brains of ... […]
Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder
on May 24, 2019 at 2:37 am
Individuals affected with different neuropsychiatric disorders such as autism (AUT), schizophrenia (SCZ) and bipolar disorder (BPD), may share similar clinical manifestations, suggesting shared ... […]
Is Schizophrenia Inherited?
on May 23, 2019 at 4:18 pm
Schizophrenia is a serious mental illness classified as a psychotic disorder. Psychosis affects a person’s thinking, perceptions, and sense of self. According to the National Alliance on Mental ... […]
Estrogen a Possible Treatment Option for Women With Schizophrenia?
on May 23, 2019 at 1:44 pm
SAN FRANCISCO — Adjunctive estrogen may be effective in reducing symptoms in women with schizophrenia and offers a potential new treatment option, new research suggests. A systematic literature review ... […]
Could a broccoli sprout extract help treat schizophrenia?
on May 20, 2019 at 11:06 pm
The current schizophrenia treatments rely on antipsychotic drugs that come with unwanted side effects. However, new research has found that a chemical called sulforaphane could reduce and even prevent ... […]
My Brother Tom’s Schizophrenia
on May 20, 2019 at 3:23 pm
My brother Tom’s slide into homelessness occurred in stages. We never knew exactly when or how he lost his apartment, or came to crash on friends’ couches, or began having run-ins with the cops. Nor ... […]
Mini Quiz: Schizophrenia Research
on May 20, 2019 at 2:20 pm
Current trials are investigating adjunctive monoclonal antibody immunotherapy in schizophrenia with all of the following agents EXCEPT: Monoclonal antibodies, also termed biologic agents or “biologics ... […]
Schizophrenia Treatment Market Expansion Projected to Gain an Uptick During 2026
on May 17, 2019 at 9:08 am
May 17, 2019 (MARKITWIRED via COMTEX) -- Schizophrenia is a chronic mental disorder, characterized by poor emotional responses, breakdown of thinking and lack of social and physical motivation. The ... […]
via Bing News